Evidence map›Paper›PMID 36781923›Full record

ArticleScientific reports2023

Author Correction: Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.

Anna Yakovleva, Ganna Kovalenko, Matthew Redlinger, Mariia G Liulchuk, Eric Bortz, Viktoria I Zadorozhna, Alla M Scherbinska, Joel O Wertheim, Ian Goodfellow, Luke Meredith and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Anna Yakovleva *Medical Sciences Division, University of Oxford, Oxford, UK.
Ganna Kovalenko *Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
Matthew RedlingerDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA.
Mariia G LiulchukState Institution "L.V. Hromashevskyi Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.
Eric BortzDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA.
Viktoria I ZadorozhnaState Institution "L.V. Hromashevskyi Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.
Alla M ScherbinskaState Institution "L.V. Hromashevskyi Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.
Joel O WertheimDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Ian GoodfellowDivision of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
Luke MeredithDivision of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
Tetyana I VasylyevaDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA. tvasylyeva@health.ucsd.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36781923
PMCPMC9924184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.